君圣泰医药-B
港股通 官网
( 02511.hk)
市盈率-7.65市净率6.10股息率0%上市时间2023-12-22股价3.65港币涨跌幅-1.35%成交金额187.14万港币换手率0.09%市值20.85亿港币H股市值20.85亿港币总股本5.71亿H股本5.71亿每手股数500上市至今年化投资收益率-41.05%港股通持仓占H股比例3.80% (7,553.17万港币2026-04-13)
所属三级行业药品 (恒生) 市盈率31.62市净率2.97股息率1.16%恒生:医疗保健业药品及生物科技药品
备注 (2): 双击编辑备注
发表讨论

君圣泰医药-B(02511) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1孔德偉Independent Non Executive Director2023-12-22--
2李靖Independent Non Executive Director2023-12-22--
3譚擘Independent Non Executive Director - A/F2023-12-22--
4于萌Executive Director2023-05-11--
5江峰Non Executive Director2022-11-16--
6馬立雄Non Executive Director2021-11-16--
7朱迅Non Executive DirectorChairman2020-11-30--
8李鋰Non Executive Director2018-10-16--
9劉利平Executive Director2018-02-28--